Feb 26 (Reuters) – Gilead Sciences Inc’s experimental cocktail to treat HIV received a green light from European regulators on Friday, boosting the chances of the drug being formally approved by the…
The post UPDATE 1-Gilead’s HIV drug gets closer to getting Europe approval appeared first on NASDAQ.